April 27, 2024 04:30 (IST)
Follow us:
Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets
New Delhi, June 23 (IBNS) Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Levofloxacin Tablets, 250mg and 500mg, the generic version of Levaquin Tablets (of Ortho-McNeil), which is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.
The total market size for Levofloxacin Tablets as per IMS is $28 Million per annum.
As on Mar 31, Jubilant Life Sciences had a total of 806 filings for formulations of which 368 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
India’s export of premium-quality basmati rice up 22% till Feb 2024 Sat, Apr 27 2024
Small Finance Banks can now apply to become universal banks under the on-tap licesning norms: RBI Sat, Apr 27 2024
Difference Between Demat and Trading Account Fri, Apr 26 2024
SBI Cards Q4FY24 net profit grows 11% YoY to Rs 662.37 cr Fri, Apr 26 2024
Stock market opens in green with Nifty near 22,600 Fri, Apr 26 2024
Vedanta Ltd Q4FY24 net profit drops 27% YoY to Rs 1,369 cr Thu, Apr 25 2024
Swiggy gets shareholders' nod for $ 1.2 billion IPO Thu, Apr 25 2024
HUL Q4FY24 profit drops 6% YoY to Rs 2,406 cr Thu, Apr 25 2024